Bank of Nova Scotia Files Pricing Supplement for New Securities
Bank of Nova Scotia files a pricing supplement for $20.6 million in contingent income auto-callable securities linked to Palantir Technologies.
GreenWood Builders Fund I LP Files New Offering Under Rule 506(b)
GreenWood Builders Fund I LP has filed a new offering under Rule 506(b), raising nearly $37 million from 28 investors to enhance investment strategies.
Quantum Genesis AI Corp. files qualification for 1-A offering
Quantum Genesis AI Corp. has filed a qualification for its 1-A offering, signaling growth potential in the industrial organic chemicals sector.
LXP Industrial Trust Confirms Effectiveness of Filing
LXP Industrial Trust announces the effectiveness of a significant filing, enhancing its operational transparency in the Real Estate Investment Trusts sector.
Aspen Neuroscience director reports major stock transactions
Aspen Neuroscience's director Andrew Spaventa reports significant stock transactions, reflecting the company's growth in the pharmaceutical sector.
Basswood Financial Fund Files to Sell Shares of Dime Bancshares
Basswood Financial Long Only Fund, L.P. files to sell shares of Dime Community Bancshares, Inc., reflecting ongoing trends in the banking sector.
Basswood Capital Management Sells Shares of Dime Community Bancshares
Basswood Capital Management files to sell shares of Dime Community Bancshares, marking a significant move in the national commercial banking sector.
Basswood Financial Fund Sells Shares of Dime Community Bancshares
Basswood Financial Fund, Ltd. reports the sale of shares in Dime Community Bancshares, indicating strategic moves in the banking sector.
Basswood Fund Files to Sell Shares in Dime Community Bancshares
Basswood Strategic Financial Fund, L.P. files to sell shares in Dime Community Bancshares, signaling ongoing investment strategy in the banking sector.
Basswood Financial Fund, L.P. Files to Sell Shares of Dime Community Bancshares
Basswood Financial Fund, L.P. files Form 144 to sell 7,987 shares of Dime Community Bancshares, signaling a strategic move in the banking sector.
Basswood Opportunity Partners sells shares of Dime Bancshares
Basswood Opportunity Partners, L.P. files Form 144 to sell shares of Dime Community Bancshares, Inc., indicating active portfolio management.
Spinner Daniel M. reports transaction in Eagle Point Credit Co
Daniel M. Spinner disclosed a transaction involving Eagle Point Credit Co's 6.6875% Notes due 2028, impacting the credit sector.
Majewski reports ownership changes in Eagle Point Credit Co.
Thomas P. Majewski's recent SEC filing reveals significant ownership changes in Eagle Point Credit Co., impacting investor confidence and company direction.
KLP 2006-N3 Family Trust to Sell 250,000 Hyatt Shares
KLP 2006-N3 Family Trust plans to sell 250,000 shares of Hyatt Hotels Corp, valued at about $46.49 million, indicating liquidity and industry trends.
Fervo Energy CEO Timothy Latimer Reports Stock Transaction
Timothy Latimer, CEO of Fervo Energy Co, reports a stock transaction involving 10,000 shares, signaling confidence in the company's future.
Chybowski to Sell 9,651 Shares of Bridgewater Bancshares
Joseph M. Chybowski plans to sell 9,651 shares of Bridgewater Bancshares, valued at about $195,046.71, reflecting trends in the banking sector.
Andreessen Horowitz Fund VIII to Sell Shares of Meta Platforms
Andreessen Horowitz Fund VIII, L.P. files to sell 20,951 shares of Meta Platforms, valued at approximately $12.78 million, impacting the tech sector.
Steve Fambro sells shares of Aptera Motors Corp
Steve Fambro sold 742 shares of Aptera Motors Corp, valued at $1,284.62, as part of ongoing stock transactions.
Assembly Biosciences Officer Sells Over $50K in Stock
Nicole S. White of Assembly Biosciences sells 2,593 shares of stock worth over $50,000, reflecting changes in executive holdings in the pharmaceutical sector.
Gaggar Anuj files to sell shares of Assembly Biosciences
Gaggar Anuj has filed to sell 2,593 shares of Assembly Biosciences, valued at approximately $50,864, reflecting insider activity in the pharmaceutical sector.